Recruitment completed for denovoSkin Phase 2 clinical trial, adult & adolescent patients
PRESS RELEASE CUTISS completes recruitment for denovoSkin™ Phase 2 clinical trial in adult and adolescent burn patients Switzerland, 7 September 2022 – CUTISS AG, a Swiss clinical-stage life sciences company focused on skin regenerative medicine and tissue engineering, has announced the completion of recruitment for the Phase 2 clinical trial of its lead product denovoSkin™ …
Recruitment completed for denovoSkin Phase 2 clinical trial, adult & adolescent patients Read More »
